Di Xiao

ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour–stromal IL-1β/NF–κB/ESE3 signalling axis

Song Gao, Shengyu Yang, Chongbiao Huang, 2022, British Journal of Cancer.

Tumor-stromal IL-1β/ NFκB / ESE3 Signaling Axis Drives Pancreatic Cancer Fibrosis, Chemoresistance, and Poor Prognosis

Hongwei Wang, Song Gao, Shengyu Yang, 2020, bioRxiv.

Proteasome inhibitor MG132 suppresses pancreatic ductal adenocarcinoma-cell migration by increasing ESE3 expression

T. Zhao, Ming Yu, Di Xiao, 2019, Oncology letters.

OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma

Hongwei Wang, Li Bao, Hui Li, 2021, Frontiers in Oncology.

IL-37/ STAT3/ HIF-1α negative feedback signaling drives gemcitabine resistance in pancreatic cancer

Hongwei Wang, Song Gao, Shengyu Yang, 2020, Theranostics.

PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer.

Hongwei Wang, Song Gao, Hui Li, 2021, Cancer Letters.